LAZZAROTTO, DAVIDE
LAZZAROTTO, DAVIDE
DMED - DIPARTIMENTO DI MEDICINA
18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia
2020-01-01 Lazzarotto, D.; Facchin, G.; Candoni, A.; Fanin, R.
Central nervous system fungal infections in allogeneic stem cell transplantation. Outcome of 24 recent cases and literature review
2019-01-01 Candoni, A.; Facchin, G.; Busca, A.; Lazzarotto, D.; Cattaneo, C.; Nadali, G.; Klimko, N.; Del Principe, M. I.; Castagnola, C.; Verga, L.; Zannier, M. E.; Calore, E.; Capelli, D.; Perruccio, K.; Melillo, L.; Fanin, R.; Pagano, L.
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience (Annals of Hematology, (2024), 103, 2, (443-448), 10.1007/s00277-023-05578-8)
2024-01-01 Tosoni, L.; Liberi, M.; Morelli, G.; Zannier, M. E.; Lazzarotto, D.; Fili, C.; Simeone, E.; Battaglia, G.; Callegari, C.; Fanin, M.; Damiani, D.; Fanin, R.; Tiribelli, M.
Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study
2022-01-01 Candoni, A.; Lazzarotto, D.; Rambaldi, A.; Dubbini, M. V.; Bresciani, P.; Busca, A.; Arcese, W.; Iori, A. P.; Sorasio, R.; Irrera, G.; Fanin, R.; Ciceri, F.; Bonifazi, F.
Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience
2019-01-01 Filì, Carla; Candoni, Anna; Zannier, Maria Elena; Olivieri, Jacopo; Imbergamo, Silvia; Caizzi, Manuela; Nadali, Gianpaolo; Di Bona, Eros; Ermacora, Anna; Gottardi, Michele; Facchinelli, Davide; Ciancia, Rosanna; Lazzarotto, Davide; Dubbini, Maria Vittoria; Festini, Gianluca; Gherlinzoni, Filippo; Michieli, Maria Grazia; Semenzato, Gianpietro; Fanin, Renato
Eravacycline: Data Based on Real Evidence
2025-01-01 Giuliano, S; Martini, L; Prataviera, F; Moreal, C; Flammini, Sarah; Terrosu, G; De Cecchis, L; Lazzarotto, D; Zhanel, Gg; Tascini, C
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group
2025-01-01 Lazzarotto, D.; Testi, A. M.; Fanin, M.; Mosna, F.; Chiaretti, S.; Papayannidis, C.; Curti, A.; Piccini, M.; Fracchiolla, N.; Fumagalli, M.; Zappasodi, P.; Imbergamo, S.; Minetto, P.; Guolo, F.; Lussana, F.; Cerrano, M.; Forghieri, F.; Leoncin, M.; Olivi, M.; Lunghi, M.; Trappolini, S.; Mazzone, C.; Defina, M.; Aprile, L.; Pasciolla, C.; Ciccone, M.; Mauro, E.; Mule, A.; Grimaldi, F.; Cambo, B.; Santoro, L.; Delia, M.; Mancini, V.; Cignetti, A.; Fanin, R.; Bonifacio, M.; Dargenio, M.; Ferrara, F.; Pizzolo, G.; Foa, R.; Candoni, A.
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study
2024-01-01 Kaiser, F.; Lunghi, M.; Cardinali, D.; Bellomarino, V.; Beldinanzi, M.; Starza, I. D.; Malfona, F.; Basilico, C. M.; Defina, M.; Mastaglio, S.; Giglio, F.; Lazzarotto, D.; Salutari, P.; Piccini, M.; Cardinali, V.; Pierini, A.; Fracchiolla, N. S.; Di Biase, F.; Annunziata, M.; Di Trani, M.; Foa, R.; Chiaretti, S.
Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles?
2021-01-01 Cojutti, P. G.; Carnelutti, A.; Lazzarotto, D.; Sozio, E.; Candoni, A.; Fanin, R.; Tascini, C.; Pea, F.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax
2023-01-01 Candoni, A.; Lazzarotto, D.; Papayannidis, C.; Piccini, M.; Nadali, G.; Dargenio, M.; Riva, M.; Fracchiolla, N.; Mellillo, L.; Dragonetti, G.; Del Principe, M. I.; Cattaneo, C.; Stulle, M.; Pasciolla, C.; De Marchi, R.; Delia, M.; Tisi, M. C.; Bonuomo, V.; Sciume, M.; Spadea, A.; Sartor, C.; Griguolo, D.; Buzzatti, E.; Basilico, C. M.; Sarlo, C.; Piccioni, A. L.; Cerqui, E.; Lessi, F.; Olivieri, A.; Fanin, R.; Luppi, M.; Pagano, L.
Stenotrophomonas maltophilia infections: Could eravacycline be a new weapon for clinicians?
2025-01-01 Giuliano, Simone; Martini, Luca; Prataviera, Francesca; Moreal, Chiara; Flammini, Sarah; Lazzarotto, Davide; Terrosu, Giovanni; De Cecchis, Lucio; Fanin, Renato; Tascini, Carlo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia | 1-gen-2020 | Lazzarotto, D.; Facchin, G.; Candoni, A.; Fanin, R. | |
| Central nervous system fungal infections in allogeneic stem cell transplantation. Outcome of 24 recent cases and literature review | 1-gen-2019 | Candoni, A.; Facchin, G.; Busca, A.; Lazzarotto, D.; Cattaneo, C.; Nadali, G.; Klimko, N.; Del Principe, M. I.; Castagnola, C.; Verga, L.; Zannier, M. E.; Calore, E.; Capelli, D.; Perruccio, K.; Melillo, L.; Fanin, R.; Pagano, L. | |
| Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience (Annals of Hematology, (2024), 103, 2, (443-448), 10.1007/s00277-023-05578-8) | 1-gen-2024 | Tosoni, L.; Liberi, M.; Morelli, G.; Zannier, M. E.; Lazzarotto, D.; Fili, C.; Simeone, E.; Battaglia, G.; Callegari, C.; Fanin, M.; Damiani, D.; Fanin, R.; Tiribelli, M. | |
| Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study | 1-gen-2022 | Candoni, A.; Lazzarotto, D.; Rambaldi, A.; Dubbini, M. V.; Bresciani, P.; Busca, A.; Arcese, W.; Iori, A. P.; Sorasio, R.; Irrera, G.; Fanin, R.; Ciceri, F.; Bonifazi, F. | |
| Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience | 1-gen-2019 | Filì, Carla; Candoni, Anna; Zannier, Maria Elena; Olivieri, Jacopo; Imbergamo, Silvia; Caizzi, Manuela; Nadali, Gianpaolo; Di Bona, Eros; Ermacora, Anna; Gottardi, Michele; Facchinelli, Davide; Ciancia, Rosanna; Lazzarotto, Davide; Dubbini, Maria Vittoria; Festini, Gianluca; Gherlinzoni, Filippo; Michieli, Maria Grazia; Semenzato, Gianpietro; Fanin, Renato | |
| Eravacycline: Data Based on Real Evidence | 1-gen-2025 | Giuliano, S; Martini, L; Prataviera, F; Moreal, C; Flammini, Sarah; Terrosu, G; De Cecchis, L; Lazzarotto, D; Zhanel, Gg; Tascini, C | |
| Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group | 1-gen-2025 | Lazzarotto, D.; Testi, A. M.; Fanin, M.; Mosna, F.; Chiaretti, S.; Papayannidis, C.; Curti, A.; Piccini, M.; Fracchiolla, N.; Fumagalli, M.; Zappasodi, P.; Imbergamo, S.; Minetto, P.; Guolo, F.; Lussana, F.; Cerrano, M.; Forghieri, F.; Leoncin, M.; Olivi, M.; Lunghi, M.; Trappolini, S.; Mazzone, C.; Defina, M.; Aprile, L.; Pasciolla, C.; Ciccone, M.; Mauro, E.; Mule, A.; Grimaldi, F.; Cambo, B.; Santoro, L.; Delia, M.; Mancini, V.; Cignetti, A.; Fanin, R.; Bonifacio, M.; Dargenio, M.; Ferrara, F.; Pizzolo, G.; Foa, R.; Candoni, A. | |
| Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study | 1-gen-2024 | Kaiser, F.; Lunghi, M.; Cardinali, D.; Bellomarino, V.; Beldinanzi, M.; Starza, I. D.; Malfona, F.; Basilico, C. M.; Defina, M.; Mastaglio, S.; Giglio, F.; Lazzarotto, D.; Salutari, P.; Piccini, M.; Cardinali, V.; Pierini, A.; Fracchiolla, N. S.; Di Biase, F.; Annunziata, M.; Di Trani, M.; Foa, R.; Chiaretti, S. | |
| Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles? | 1-gen-2021 | Cojutti, P. G.; Carnelutti, A.; Lazzarotto, D.; Sozio, E.; Candoni, A.; Fanin, R.; Tascini, C.; Pea, F. | |
| Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax | 1-gen-2023 | Candoni, A.; Lazzarotto, D.; Papayannidis, C.; Piccini, M.; Nadali, G.; Dargenio, M.; Riva, M.; Fracchiolla, N.; Mellillo, L.; Dragonetti, G.; Del Principe, M. I.; Cattaneo, C.; Stulle, M.; Pasciolla, C.; De Marchi, R.; Delia, M.; Tisi, M. C.; Bonuomo, V.; Sciume, M.; Spadea, A.; Sartor, C.; Griguolo, D.; Buzzatti, E.; Basilico, C. M.; Sarlo, C.; Piccioni, A. L.; Cerqui, E.; Lessi, F.; Olivieri, A.; Fanin, R.; Luppi, M.; Pagano, L. | |
| Stenotrophomonas maltophilia infections: Could eravacycline be a new weapon for clinicians? | 1-gen-2025 | Giuliano, Simone; Martini, Luca; Prataviera, Francesca; Moreal, Chiara; Flammini, Sarah; Lazzarotto, Davide; Terrosu, Giovanni; De Cecchis, Lucio; Fanin, Renato; Tascini, Carlo |